心脏骤停后目标温度管理32 °C与36 °C按初始病情严重程度的不同效应:来自两个国际数据集的分析
研究利用法国SDEC登记(2011年5月至2017年12月,2723例)与北美ROC-CCC试验(2011年6月至2015年5月,4202例)数据,按ICU入院时改良心脏骤停医院预后(mCAHP)评分三分位分层,探讨TTM32-36与出院时神经功能良好的关联。法国数据集中低严重程度(校正OR 1.63,95%CI 1.15-2.30,P=.006)和高严重程度(校正OR 1.94,95%CI 1.06-3.54,P=.030)三分位患者中TTM32-36与更好神经结局独立相关;北美数据集中相应校正OR分别为1.36(95%CI 1.05-1.75,P=.020)和2.42(95%CI 1.38-4.24,P=.002);两个数据集中等严重程度组均未观察到关联。作者认为需进一步研究评估院外心脏骤停后的个体化温度控制。
要点
- 法国SDEC数据集2723例中,mCAHP低严重程度三分位患者TTM32-36与出院神经功能良好独立相关(校正OR 1.63,95%CI 1.15-2.30,P=.006)。
- 法国SDEC数据集中,mCAHP高严重程度三分位患者TTM32-36与出院神经功能良好独立相关(校正OR 1.94,95%CI 1.06-3.54,P=.030)。
- 北美ROC-CCC数据集4202例中,低严重程度三分位校正OR 1.36(95%CI 1.05-1.75,P=.020),高严重程度三分位校正OR 2.42(95%CI 1.38-4.24,P=.002)。
- 两个数据集的中等严重程度组均未观察到TTM32-36与结局的关联。
- 出院时神经功能良好者法国数据集728例(27%),北美数据集1239例(29%)。
适用人群与场景
- 院外心脏骤停复苏后入住ICU的昏迷患者,数据来自法国SDEC登记(2011年5月至2017年12月)和北美ROC-CCC试验(2011年6月至2015年5月)。
- 按ICU入院时改良心脏骤停医院预后(mCAHP)评分三分位分为低、中、高严重程度组。
诊断标准与关键阈值
- 采用改良版心脏骤停医院预后(mCAHP)评分评估ICU入院时严重程度,并分为严重程度三分位。
研究设计与关键结果
- 研究设计:基于法国SDEC前瞻性登记(2011年5月至2017年12月)和北美ROC-CCC试验(2011年6月至2015年5月)数据的分析,分别纳入2723例和4202例患者。
- 主要终点出院时神经功能良好:法国数据集728例(27%),北美数据集1239例(29%)。
- 法国数据集:mCAHP低严重程度三分位中TTM32-36与出院神经功能良好独立相关(校正OR 1.63,95%CI 1.15-2.30,P=.006);高严重程度三分位校正OR 1.94(95%CI 1.06-3.54,P=.030)。
- 北美数据集:低严重程度三分位校正OR 1.36(95%CI 1.05-1.75,P=.020);高严重程度三分位校正OR 2.42(95%CI 1.38-4.24,P=.002)。
- 两个数据集的中等严重程度组均未观察到TTM32-36与结局的关联。
证据类型、等级与局限
- 证据类型:基于前瞻性收集数据的两个国际数据集分析(法国SDEC登记与北美ROC-CCC试验)。
- 作者结论:TTM32-36与ICU入院时mCAHP评分为低和高严重程度的患者更好结局显著相关;需进一步研究评估院外心脏骤停后的个体化温度控制。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,TTM32-36在ICU入院时mCAHP评分为低和高严重程度的院外心脏骤停后昏迷患者中与更好结局显著相关,中等严重程度患者中未观察到关联。
- 作者建议需进一步研究评估院外心脏骤停后的个体化温度控制。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Recent guidelines have emphasized actively avoiding fever to improve outcomes in patients who are comatose following resuscitation from cardiac arrest (ie, out-of-hospital cardiac arrest). However, whether targeted temperature management between 32 °C and 36 °C (TTM32-36) can improve neurologic outcome in some patients remains debated.
RESEARCH QUESTION: Is there an association between the use of TTM32-36 and outcome according to severity assessed at ICU admission using a previously derived risk score?
STUDY DESIGN AND METHODS: Data prospectively collected in the Sudden Death Expertise Center (SDEC) registry (France) between May 2011 and December 2017 and in the Resuscitation Outcomes Consortium Continuous Chest Compressions (ROC-CCC) trial (United States and Canada) between June 2011 and May 2015 were used for this study. Severity at ICU admission was assessed through a modified version of the Cardiac Arrest Hospital Prognosis (mCAHP) score, divided into tertiles of severity. The study explored associations between TTM32-36 and favorable neurologic status at hospital discharge by using multiple logistic regression as well as in tertiles of severity for each data set.
RESULTS: A total of 2,723 patients were analyzed in the SDEC data set and 4,202 patients in the ROC-CCC data set. A favorable neurologic status at hospital discharge occurred in 728 (27%) patients in the French data set and in 1,239 (29%) patients in the North American data set. Among the French data set, TTM32-36 was independently associated with better neurologic outcome in the tertile of patients with low (adjusted OR, 1.63; 95% CI, 1.15-2.30; P = .006) and high (adjusted OR, 1.94; 95% CI, 1.06-3.54; P = .030) severity according to mCAHP at ICU admission. Similar results were observed in the North American data set (adjusted ORs of 1.36 [95% CI, 1.05-1.75; P = .020] and 2.42 [95% CI, 1.38-4.24; P = .002], respectively). No association was observed between TTM32-36 and outcome in the moderate groups of the two data sets.
INTERPRETATION: TTM32-36 was significantly associated with a better outcome in patients with low and high severity at ICU admission assessed according to the mCAHP score. Further studies are needed to evaluate individualized temperature control following out-of-hospital cardiac arrest.
参考来源
- Lascarrou JB, Dumas F, Bougouin W, et al. Differential Effect of Targeted Temperature Management Between 32 °C and 36 °C Following Cardiac Arrest According to Initial Severity of Illness: Insights From Two International Data Sets. Chest. 2022. PMID: 36445800. doi:10.1016/j.chest.2022.10.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。